In the current study with a CCl4-induced fibrosis model, treatment with CpG attenuates the WT hepatic fibrosis, serum ALT levels (Figure 1C) and liver CD8 infiltrates (Figure 2). This evidence concerns the gene GPT and Hepatic fibrosis.